MDT · News · 20261001N
Cardiac Ablation Expansion
Medtronic plc · 2026-10-01 · Importance 38 · Surprise 60 · In source text
Medtronic received U.S. regulatory clearance for Affera Prism-2 Mapping Software and a European CE mark for the PulseSelect ProxBox Adapter with Proximity Indicator software. The products are intended to improve visualization and provide real-time feedback during cardiac ablation procedures. The launches strengthen Medtronic’s positioning in the competitive pulsed field ablation market and support adoption of its Affera and PulseSelect platforms.
Key facts
- Medtronic announced it has received regulatory clearances in both the U.S. and Europe for its Affera Prism-2 Mapping Software and a CE mark for the PulseSelect ProxBox Adapter with Proximity Indicator software. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Medtronic announced it has received regulatory clearances in both the U.S. and Europe for its Affera Prism-2 Mapping Software and a CE… |